Qingdao NovelBeam Technology Co. Ltd. A (688677) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.033x

Based on the latest financial reports, Qingdao NovelBeam Technology Co. Ltd. A (688677) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥44.04 Million ≈ $6.44 Million USD) by net assets (CN¥1.32 Billion ≈ $192.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688677 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Qingdao NovelBeam Technology Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Qingdao NovelBeam Technology Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qingdao NovelBeam Technology Co. Ltd. A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shenzhen Mason Technologies Co Ltd
SHE:002654
0.155x
Farasis Energy Gan Zhou Co Ltd
SHG:688567
0.036x
Sapiens International Corporation NV
TA:SPNS
0.020x
INTERNET IN.JP.ADR 1 ON
F:IIJ
0.110x
The Navigator Company SA
LS:NVG
0.026x
Navios Maritime Partners LP Unit
NYSE:NMM
0.037x
Northern Oil & Gas Inc
NYSE:NOG
0.181x
Shenzhen Bluetrum Technology Co. Ltd. A
SHG:688332
N/A

Annual Cash Flow Conversion Efficiency for Qingdao NovelBeam Technology Co. Ltd. A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Qingdao NovelBeam Technology Co. Ltd. A from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Qingdao NovelBeam Technology Co. Ltd. A (688677) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.34 Billion
≈ $196.79 Million
CN¥159.78 Million
≈ $23.38 Million
0.119x +38.09%
2024-12-31 CN¥1.31 Billion
≈ $191.03 Million
CN¥112.32 Million
≈ $16.44 Million
0.086x -29.65%
2023-12-31 CN¥1.29 Billion
≈ $189.17 Million
CN¥158.12 Million
≈ $23.14 Million
0.122x +43.26%
2022-12-31 CN¥1.22 Billion
≈ $178.89 Million
CN¥104.38 Million
≈ $15.27 Million
0.085x -10.13%
2021-12-31 CN¥1.09 Billion
≈ $160.20 Million
CN¥104.01 Million
≈ $15.22 Million
0.095x -73.54%
2020-12-31 CN¥319.69 Million
≈ $46.78 Million
CN¥114.78 Million
≈ $16.80 Million
0.359x -3.39%
2019-12-31 CN¥224.80 Million
≈ $32.90 Million
CN¥83.54 Million
≈ $12.22 Million
0.372x +76.39%
2018-12-31 CN¥229.45 Million
≈ $33.58 Million
CN¥48.34 Million
≈ $7.07 Million
0.211x -38.23%
2017-12-31 CN¥193.68 Million
≈ $28.34 Million
CN¥66.06 Million
≈ $9.67 Million
0.341x +32.46%
2016-12-31 CN¥142.21 Million
≈ $20.81 Million
CN¥36.62 Million
≈ $5.36 Million
0.257x +52.17%
2015-12-31 CN¥94.77 Million
≈ $13.87 Million
CN¥16.04 Million
≈ $2.35 Million
0.169x -14.27%
2014-12-31 CN¥69.64 Million
≈ $10.19 Million
CN¥13.75 Million
≈ $2.01 Million
0.197x -42.75%
2013-12-31 CN¥63.19 Million
≈ $9.25 Million
CN¥21.79 Million
≈ $3.19 Million
0.345x --

About Qingdao NovelBeam Technology Co. Ltd. A

SHG:688677 China Medical Instruments & Supplies
Market Cap
$2.09 Billion
CN¥14.27 Billion CNY
Market Cap Rank
#6177 Global
#1294 in China
Share Price
CN¥119.01
Change (1 day)
-2.45%
52-Week Range
CN¥36.31 - CN¥154.98
All Time High
CN¥154.98
About

Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more